Use of Auto-Injector for Methotrexate Subcutaneous Self-Injections: High Satisfaction Level and Good Compliance in SELF-I Study, a Randomized, Open-Label, Parallel Group Study-Reference-Cited by-同舟云学术

Use of Auto-Injector for Methotrexate Subcutaneous Self-Injections: High Satisfaction Level and Good Compliance in SELF-I Study, a Randomized, Open-Label, Parallel Group Study

Published:2018-12-13 Issue:1 Volume:6 Page:47-60
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Saraux Alain,Hudry Christophe,Zinovieva Elena,Herman-Demars Hélène,Aouadi Lahouari,Arif Azzedine,Arty-Hue Heyliette,Banal Frederic,Banse Christopher,Baron Jean-Jacques,Basch Andre,Berton Valerie,Bitar Salma,Cantagrel Alain,Cayla Pierre,Combe Bernard,Cornaille-Lafage Genevieve,Duplantier Dominique,Dellaroli Martine Elbaz,Ferrazzi Veronique,Flipo Rene-Marc,Fulpin Jean,Gardiol Jean-Claude,Guilyardi Cecile,Hacene Anissa,Hudry Christophe,Jarrige Dominique,Jourdan Mireille,Laillet Herve,Lamer François,Lassoued Slim,Lupo-Mattatia Geraldine,Marzynski Eric,Melac-Ducamp Sylvie,Monod Pierre,Naim Claude,Negrier-Chassaing Isabelle,Ngasseu Pierre,Plat Dominique,Prothery Daniele,Roch-Bras Françoise,Saraux Alain,Schaeverbeke Thierry,Sebaa Karim,Senbel Eric,Soubrier Martin,Sourisseau-Diverres Gaëlle,Soutif Dominique,Straus Catherine,Tauveron Philippe,Timsit Marie-Agnes,Vedere Valerie,Viu Philippe,Werner-Leyval Stephanie,

Funder

Nordic Pharma SAS

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40744-018-0134-2.pdf

Reference38 articles.

1. Guillemin F, Saraux A, Guggenbuhl P, et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis. 2005;64(10):1427–30. https://doi.org/10.1136/ard.2004.029199.

2. Jacobs JW. Lessons for the use of non-biologic anchor treatments for rheumatoid arthritis in the era of biologic therapies. Rheumatology. 2012;51(suppl_4):iv27–33.

3. Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–77.

4. Choi HK, Hernán MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173–7.

5. Wasko MCM, Dasgupta A, Hubert H, et al. Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheumatol. 2013;65(2):334–42.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study;Expert Opinion on Biological Therapy;2024-06-21

2. International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector;Patient Preference and Adherence;2024-03

3. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review;Arthritis Care & Research;2023-06-12

4. Use of parenteral methotrexate in rheumatic diseases: A systematic review;Reumatología Clínica (English Edition);2022-04

5. Learning from chess engines: how reinforcement learning could redefine clinical decision-making in rheumatology;Annals of the Rheumatic Diseases;2022-02-08